| Ms Kassandra Maree French, MA | |
|
303 Beechwood St, Cohasset, MA 02025-1521 | |
| (201) 213-6228 | |
| Not Available |
| Full Name | Ms Kassandra Maree French |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 303 Beechwood St, Cohasset, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972766392 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 1428 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kassandra Maree French, MA 303 Beechwood St, Cohasset, MA 02025-1521 Ph: (201) 213-6228 | Ms Kassandra Maree French, MA 303 Beechwood St, Cohasset, MA 02025-1521 Ph: (201) 213-6228 |
News Archive
"Tonight the U.S. House of Representatives showed they have heard the voice of America's families by passing the Affordable Health Care for America Act. Now the Senate must deliver, without delay, on the promise of meaningful health care reform," said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic Health, the nation's leading Hispanic health advocacy group.
Health provider follow-ups delivered via computer or smartphone is a feasible alternative to in-person patient follow-ups for some pediatric cardiac conditions, according to the findings of a pilot study presented at the AHA Scientific Sessions this week.
At approximately 2:30 pm on Monday, January 25th "Penn Medicine Team One" - the first medical team from Penn Medicine to fly to Haiti to provide expert medical care - departed from the Philadelphia International Airport.
A study in the Journal of Biological Chemistry identifies a new therapeutic approach to treat prostate cancer. Conducted at Cincinnati Children's Hospital Medical Center, the research shows that expression of the FoxM1 protein is essential for prostate cancer to develop in mouse models. The study appears in the journal's Aug. 2 edition.
Integrity Applications, Inc., developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, through its wholly-owned subsidiary, Integrity Applications Ltd., into distribution agreements for the GlucoTrack device in Italy, Thailand and Uruguay.
› Verified 3 days ago